pubmed-article:3113537 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C0010068 | lld:lifeskim |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C0017258 | lld:lifeskim |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C0012854 | lld:lifeskim |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C0003601 | lld:lifeskim |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
pubmed-article:3113537 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:3113537 | pubmed:issue | 6587 | lld:pubmed |
pubmed-article:3113537 | pubmed:dateCreated | 1987-9-29 | lld:pubmed |
pubmed-article:3113537 | pubmed:abstractText | The prevalence of an uncommon allelic variant (S2) of the apoprotein AI-CIII-AIV gene cluster was determined in non-insulin-dependent diabetics with or without evidence of coronary heart disease and in controls. Frequencies of the S2 allele were 14% for diabetics with coronary heart disease compared with 2% for non-diabetics with no clinical evidence of occlusive vascular disease. No subject with the S2 allele was detected among a further group of matched diabetics without clinical features of macrovascular disease. The results suggest that a genetic component contributes to the susceptibility to coronary heart disease in non-insulin-dependent diabetics. Whether the observed deoxyribonucleic acid variant is aetiological for atherosclerosis or in linkage disequilibrium with other atherogenic loci on chromosome 11 remains to be clarified. | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:language | eng | lld:pubmed |
pubmed-article:3113537 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:3113537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3113537 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3113537 | pubmed:month | Jun | lld:pubmed |
pubmed-article:3113537 | pubmed:issn | 0267-0623 | lld:pubmed |
pubmed-article:3113537 | pubmed:author | pubmed-author:GaltonD JDJ | lld:pubmed |
pubmed-article:3113537 | pubmed:author | pubmed-author:YudkinJ SJS | lld:pubmed |
pubmed-article:3113537 | pubmed:author | pubmed-author:ThomasD JDJ | lld:pubmed |
pubmed-article:3113537 | pubmed:author | pubmed-author:TrembathR CRC | lld:pubmed |
pubmed-article:3113537 | pubmed:author | pubmed-author:HendraT JTJ | lld:pubmed |
pubmed-article:3113537 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3113537 | pubmed:day | 20 | lld:pubmed |
pubmed-article:3113537 | pubmed:volume | 294 | lld:pubmed |
pubmed-article:3113537 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3113537 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3113537 | pubmed:pagination | 1577-8 | lld:pubmed |
pubmed-article:3113537 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:meshHeading | pubmed-meshheading:3113537-... | lld:pubmed |
pubmed-article:3113537 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3113537 | pubmed:articleTitle | Deoxyribonucleic acid polymorphism of the apoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes. | lld:pubmed |
pubmed-article:3113537 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3113537 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3113537 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3113537 | lld:pubmed |